Operating Income (Loss) in USD of PAVmed Inc. from Q1 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
PAVmed Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2016 to Q3 2025.
  • PAVmed Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$4.84M, a 58.2% increase year-over-year.
  • PAVmed Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$20.2M, a 63.7% increase year-over-year.
  • PAVmed Inc. annual Operating Income (Loss) for 2024 was -$44.5M, a 35.3% increase from 2023.
  • PAVmed Inc. annual Operating Income (Loss) for 2023 was -$68.8M, a 24.5% increase from 2022.
  • PAVmed Inc. annual Operating Income (Loss) for 2022 was -$91.1M, a 67.5% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

PAVmed Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$20.2M -$4.84M +$6.73M +58.2% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$26.9M -$4.72M +$8.97M +65.5% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$35.9M -$5.45M +$8.59M +61.2% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$44.5M -$5.19M +$11.2M +68.3% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025
Q3 2024 -$55.7M -$11.6M +$3.95M +25.4% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$59.6M -$13.7M +$2.8M +17% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$62.4M -$14M +$6.37M +31.2% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$68.8M -$16.4M +$8.22M +33.4% 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025
Q3 2023 -$77M -$15.5M +$7.84M +33.5% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$84.9M -$16.5M +$7M +29.8% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 -$91.9M -$20.4M -$766K -3.9% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$91.1M -$24.6M -$4.92M -25% 01 Oct 2022 31 Dec 2022 10-K 25 Mar 2024
Q3 2022 -$86.2M -$23.4M -$9.7M -71% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$76.5M -$23.5M -$10.5M -81.1% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$66M -$19.6M -$11.6M -143% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$54.4M -$19.7M -$12.1M -160% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 -$42.3M -$13.7M -$8.14M -147% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$34.1M -$13M -$7.96M -159% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$26.2M -$8.08M -$2.82M -53.8% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$23.4M -$7.56M -$2.97M -64.7% 01 Oct 2020 31 Dec 2020 10-K 06 Apr 2022
Q3 2020 -$20.4M -$5.53M -$2.28M -70.4% 01 Jul 2020 30 Sep 2020 10-Q 22 Nov 2021
Q2 2020 -$18.1M -$5.01M -$1.7M -51.1% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$16.4M -$5.25M -$2.11M -67.1% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$14.3M -$4.59M -$1.28M -38.5% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 -$13M -$3.24M -$675K -26.3% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 -$12.3M -$3.32M -$580K -21.2% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$11.8M -$3.14M -$1.2M -61.8% 01 Jan 2019 31 Mar 2019 10-Q 28 May 2020
Q4 2018 -$10.6M -$3.31M -$1.42M -75.4% 01 Oct 2018 31 Dec 2018 10-K 14 Apr 2020
Q3 2018 -$9.14M -$2.57M -$601K -30.5% 01 Jul 2018 30 Sep 2018 10-Q 19 Nov 2019
Q2 2018 -$8.54M -$2.74M -$717K -35.5% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$7.82M -$1.94M +$213K +9.86% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 -$8.03M -$1.89M -$178K -10.4% 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019
Q3 2017 -$7.86M -$1.97M -$39.3K -2.04% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$7.82M -$2.02M -$707K -53.8% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 -$7.11M -$2.16M -$1.46M -209% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018
Q4 2016 -$5.65M -$1.71M 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2018
Q3 2016 -$1.93M 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$1.31M 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 -$697K 01 Jan 2016 31 Mar 2016 10-Q 22 May 2017

PAVmed Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$44.5M +$24.3M +35.3% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025
2023 -$68.8M +$22.3M +24.5% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025
2022 -$91.1M -$36.7M -67.5% 01 Jan 2022 31 Dec 2022 10-K 25 Mar 2024
2021 -$54.4M -$31M -133% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023
2020 -$23.4M -$9.06M -63.4% 01 Jan 2020 31 Dec 2020 10-K 06 Apr 2022
2019 -$14.3M -$3.73M -35.3% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 -$10.6M -$2.53M -31.5% 01 Jan 2018 31 Dec 2018 10-K 14 Apr 2020
2017 -$8.03M -$2.38M -42.2% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019
2016 -$5.65M 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.